Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Biagio Ricciuti
Oct 5, 2024, 12:11 |
Blog
Biagio Ricciuti: Stephen Liu on the evolving treatment landscape for SCLC
Biagio Ricciuti shared a post on X: "Comprehensive overview of the evolving treatment landscape for…
Sep 6, 2024, 13:28 |
Insight
Biagio Ricciuti: How adaptive mechanisms and increased GTP loading confer resistance to KRAS G12C OFF
Biagio Ricciuti shared on X: “Our in Nature Communications our collaborative effort showing how adaptive mechanisms…
Aug 27, 2024, 23:18 |
Insight
Explore the current therapeutic landscape for Lung Cancer with Biagio Ricciuti at the upcoming ILCS24
International Lung Cancer Summit (ILCS) shared on X: “What is the current therapeutic landscape for Lung…
Aug 18, 2024, 06:12 |
Blog
Biagio Ricciuti: KEAPness signature outperforms deleterious KEAP1 mutations in predicting ICI efficacy in NSCLC
Biagio Ricciuti shared on X: "Sharing our latest effort out in Clinical Cancer Research! This multicenter…
Aug 12, 2024, 06:16 |
Insight
Biagio Ricciuti: In vivo vulnerabilities to GPX4 and HDAC inhibitors in BRAF V600E lung adenocarcinoma
Biagio Ricciuti shared a post on LinkedIn about his recent paper, commenting: “Our collaborative effort…
Aug 12, 2024, 02:37 |
Blog
Biagio Ricciuti: Vulnerabilities to GPX4 and HDAC inhibitors in BRAF V600E lung adenocarcinoma
Biagio Ricciuti posted on X about recent paper by Marie-Julie Nokin et al., titled "In…
Aug 7, 2024, 20:03 |
Insight
Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion summarized by Biagio Ricciuti
Biagio Ricciuti shared a post on X: "Recurrence of Non–Small Cell Lung Cancer With Visceral…
Jul 21, 2024, 20:02 |
Blog
Biagio Ricciuti: Join us in Lausanne for the 2024 International Lung Cancer Summit
Biagio Ricciuti shared a post on X by the International Lung Cancer Summit, adding: "Join…
Jul 10, 2024, 02:17 |
Blog
Biagio Ricciuti: Resistance mechanisms in insertion-mutant NSCLC
Biagio Ricciuti shared on X: "Resistance mechanisms to EGFR TKIs in EGFR ex 20 insertion-mutant NSCLC:…
Jul 1, 2024, 02:31 |
Blog
Biagio Ricciuti receives a 2024 IASLC YIA to develop new therapies for KRAS amplified NSCLC
Biagio Ricciuti shared a post by Dana-Farber News, on X: "Thrilled to receive a 2024…
1
2
3
4
All:
36
Posts:
1 - 10
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube